Results 211 to 220 of about 25,343 (258)

Drug-Induced Tardive Dyskinesia

1981
Drug-induced tardive dyskinesia, which occurs in the course of long-term administration of psychotropic drugs, especially neuroleptics, and persists for years even after drug removal, began to be reported in the late 1950s. Since then, more than 100 investigations on this subjects have been described.
openaire   +2 more sources

Drug-Induced and Other Orofacial-Cervical Dyskinesias

Annals of Internal Medicine, 1981
Tardive dyskinesia is one of the most prevalent and disabling of the iatrogenic disorders. Characterized by involuntary movements of the orofacial-cervical musculature that develop after prolonged use of neuroleptic drugs, it is sometimes confused with other involuntary movements involving predominantly the head and neck region.
openaire   +2 more sources

New insights into the mechanism of drug-induced dyskinesia

CNS Spectrums, 2012
Dyskinesia is an extrapyramidal movement disorder characterized by involuntary, repetitive, irregular motions that affect the mouth and face and/or the limbs and trunk. Tardive dyskinesia (TD) is a well-known complication of long-term treatment with antipsychotic drugs.
Loonen, Anton J. M., Ivanova, Svetlana A.   +1 more
openaire   +2 more sources

Pathophysiological basis of drug-induced dyskinesias in Parkinson's disease

Brain Research Reviews, 2005
Drug-induced dyskinesias (DID) represent a troublesome, dose-limiting, and common complication of long-term pharmacotherapy in Parkinson's disease (PD) patients. The pathophysiological basis and clinical nature of DID is of major interest for clinicians and neuroscientists.
Milind, Deogaonkar, Thyagarajan, Subramanian   +1 more
openaire   +2 more sources

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

Schizophrenia Research, 1991
Neuroleptic (antipsychotic) drug-induced acute extrapyramidal syndromes (EPS) and the late onset tardive dyskinesia (TD) are the major side effects that limit the use of these highly efficacious agents. The appropriate strategy for controlling these side effects is based on the clinical presentations, pathophysiological mechanisms, and contributions of
openaire   +2 more sources

Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.

Acta neurologica Belgica, 1999
This study attempted to contribute to the subtyping of tardive dyskinesia (TD) by studying the effects of age, sex, psychiatric diagnosis and duration of illness on the severity and topographic distribution of dyskinesia, and to describe the topographic distribution of drug-induced dyskinesia (DID) and drug-induced parkinsonism (DIP) in detail by ...
M C, Akbostanci, E C, Atbaşoğlu, H, Balaban   +2 more
openaire   +1 more source

Quantifying drug induced dyskinesia in Parkinson's disease patients using standardized videos

2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2008
This paper presents a video based method to quantify drug induced dyskinesias in Parkinson's disease (PD) patients. Dyskinetic movement in standard clinical videos of patients is analyzed by tracking landmark points on the video frames using non-rigid image registration.
Anusha S, Rao, Robert E, Bodenheimer, Thomas L, Davis, Rui, Li, Cissy, Voight, Benoit M, Dawant   +5 more
openaire   +2 more sources

Neuroradiological Covariates of Drug-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenia

International Journal of Neuroscience, 1991
Computed tomographic (CT) studies have demonstrated structural brain abnormalities including cortical atrophy and enlarged lateral ventricles in a subset of schizophrenic patients including those with abnormal involuntary movements. In the following series of studies, we present our findings pertaining to neuroradiological covariates of drug-induced ...
R, Sandyk, S R, Kay
openaire   +2 more sources

Underrecognition of tardive dyskinesia and drug-induced parkinsonism by psychiatric residents

General Hospital Psychiatry, 1992
Recognition of tardive dyskinesia (TD) and other neuroleptic, drug-induced, extrapyramidal side effects presents a major challenge in modern clinical psychopharmacology. Failure to recognize these disorders can lead to poor patient care and may contribute to societal pressure for external control of psychiatric practice.
T E, Hansen, W L, Brown, R M, Weigel, D E, Casey   +3 more
openaire   +2 more sources

TREATMENT OF DRUG-INDUCED DYSKINESIAS

The Lancet, 1970
A, Villeneuve, Z, Böszörményi
openaire   +4 more sources